Medikinet
ADHD Treatment Overview:
Medikinet
is an ADHD treatment drug which contains methylphenidate
and is an active CNS stimulant. Medikinet can form part
of a comprehensive treatment programme for attention-deficit/hyperactivity
disorder (ADHD) and is suitable for prescription to children
over 6 years of age when remedial measures alone prove insufficient.
ADHD
treatment pharmaceuticals, such as Medikinet, should not
be used in isolation, but as part of a comprehensive treatment
programme which typically includes psychological, educational
and social measures, the aim being to stabilise children
with this behavioural syndrome characterized by symptoms
which may include chronic history of short attention span,
distractibility, emotional lability, impulsivity, moderate
to severe hyperactivity, minor neurological signs and abnormal
EEG. As yet there is no eveidence to suggest that use of
Medikinet impairs learning in any way.
Medikinet
and Medikinet XL treatment is not indicated in all children
with this syndrome and the decision to use these medicinal
product must be based on a very thorough assessment of the
severity of the child's symptoms.
Medikinet
and Medikinet XL treat the patient by having a mild CNS
stimulant effect with more prominent effects on mental than
on motor activities. Its mode of action is thought to be
due to cortical stimulation and possibly to stimulation
of the reticular activating system.
For
more information about Flynn Pharma and its other licensed
pharmaceutical products click 'here'
|
